secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2021-08-11T23:59:59+00:00
Accession:  0000950170-21-001270
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Health Q2 revenue $160.5M (+91% YoY), initiates FY2021 guidance
--------------------------------------------------------------------------

- Revenue $160.5M, up 91% YoY; net loss $70M includes $29.5M stock comp and $10M foundation endowment.
- Adjusted EBITDA $14.5M (+39% YoY); total clinicians 3,975, up 94% YoY.
- IPO completed June 10, net proceeds $548.9M used to retire debt and for corporate purposes.
- FY2021 guidance: revenue $668M-$678M, Center Margin $198M-$208M, Adjusted EBITDA $47M-$53M.
- Opened 35 de novo centers, entered 5 new states, completed 10 acquisitions in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017021001270/0000950170-21-001270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017021001270/lfst-20210811.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-001270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer